Compass Therapeutics

CAMBRIDGE, MA · Founded 2018 · CIK 0001738021 · Biotech · Public

Therapeutic lead identification platforms using computational methods

compasstherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$256M
2 Form D · Jul 2020
75 months since last filing
Contracts
—
No federal contracts on record
Patents
40
15 granted · 25 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$60,482,210
Private capital raised· 2 of 2 same dayForm D · SEC$195,276,780
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1997JYANT, INC.——
1998CERAMIDE THERAPEUTICS, LLC——
1999CLAIRIgene——
2000Compass Therapeutics—$256M
2001NiKang Therapeutics—$200M
2002Regulonix——
2003FORMATION VENTURE ENGINEERING FOUNDRY INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Vered Bisker-LeibExecutive Officer
  • Philip FerneauDirector
  • Carl GordonDirector
  • Thomas SchuetzDirector · Executive Officer
  • Stephen SquintoDirector
  • Julie SunderlandDirector

Patents

USPTO · 15 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.